Internal Server Error

About Citrine Capital

Citrine Capital is a venture capital firm founded in 2019. It is primarily based out of Puchong, Malaysia. As of Jan 2022, Citrine Capital has invested in 7 companies. It primarily invests in Seed round in Singapore based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Consumer. Most recently it participated in the $***** Series A round of Smarter Health Overall, Citrine Capital portfolio has seen 1 IPO, namely Foundation Healthcare. A lot of funds co-invest with Citrine Capital, with names like Elev8 sharing a substantial percentage of its portfolio.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio IPOs

Citrine Capital's List of Top Investments

Citrine Capital has a portfolio of 7 companies. Their most notable investments include ThoughtFull and reach52.Their portfolio spans across Singapore and Malaysia. They have invested in Enterprise Applications, HealthTech, Consumer and 3 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Citrine Capital:
SaaS-based digital mental health solutions for employees, individuals, and insurers. The company has developed a digital platform that allows organizations to assist employees with mental health management. The company provides mental health programs, therapy sessions, intervention programs, and educational content for users. The app-based platform can be used by insurers to provide health interventions.

Key facts about ThoughtFull

  • Founded Year: 2019
  • Location: Kuala Lumpur (Malaysia)
  • Annual Revenue: $0 - $1M as on Dec 31, 2023
  • Stage: Seed
  • Total Funding till date: $5.1M
  • Employee Count: 104 as on Aug 31, 2026
  • Investors: Vulpes Investment Management, Grab and 8 Others
  • Latest Funding Round: Seed, Mar 23, 2023, $*****
  • Highlight: Editors' Pick
Provider of value-based care management and benefit administrative tool for providers. The company has developed software that assists in accessing value-based care services. It has features for business collaborations and more.

Key facts about reach52

Mesh Bio provides software for chronic disease management through predictive analytics. The software translates clinical data and numbers into actionable insights that help patients better manage their health, lifestyle, and disease risks. The software provides clinical decision support for healthcare professionals

Key facts about Mesh Bio

  • Founded Year: 2018
  • Location: Singapore (Singapore)
  • Annual Revenue: SGD 0 - 1M as on Dec 31, 2022
  • Stage: Series A
  • Total Funding till date: $6.5M
  • Employee Count: 28 as on Aug 31, 2026
  • Investors: SEEDS Capital, YL Ventures and 17 Others
  • Latest Funding Round: Series A, Oct 12, 2023, $*****
  • Highlight: Editors' Pick

Key facts about Foundation Healthcare

5. BiiB

BiiB is an app-based running event management platform. Features include event recording, challenge management, and more. Additionally, it also motivates runners to create and manage a runner community. The company's clientele includes Yakult, BROOKS, and MaGIC among others. Its mobile app is available for Android and iOS devices.

Key facts about BiiB

Citrine Capital's Investments by Stage

Citrine Capital has made 1 investment in Seed stage with an average round size of $1.8M and 1 investment in Series A stage with an average round size of $4.07M.

Citrine Capital's Investments by Sector

Citrine Capital has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech and FinTech. Notably, it has invested in 6 Tech companies, 5 Enterprise (B2B) companies, 5 Software companies and at least 2 companies focusing on Consumer (B2C).
Here are Citrine Capital's investments by sector:
Sector
No. of Investments
Enterprise Applications
2
HealthTech
2
FinTech
1
Breakdown of Citrine Capital's investments by sectorsEnterprise Applic... (2)HealthTech (2)
Note: We have considered here, only first round of investments

Citrine Capital's Investments by Geography

Citrine Capital has made most investments in Singapore (2).

Citrine Capital's recent investments

Citrine Capital has not made any investment in 2026 so far.
Here are the most recent investments by Citrine Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jan 03, 2022
Singapore
Series A
4323
Mar 10, 2021
Singapore
Seed
2908
  [+2]

IPOs and Publicly Listed companies in Citrine Capital's Portfolio

1 of Citrine Capital's portfolio company became public -  Foundation Healthcare. It got listed on the Singapore stock exchange. ( SGX), in Jul 2026 at marketcap of $188M
Here are Citrine Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jul 08, 2026
-
-
3515

Co-investors of Citrine Capital

Over the past 5 years, 10 investors have co-invested in Citrine Capital's portfolio companies. This includes funds and angels.

  • Top Co-investors of Citrine Capital: 7 investors entered a company along with Citrine Capital. These include investors like Elev8 (1 company).
  • Invested after Citrine Capital: A total of 3 investors have invested in Citrine Capital's portfolio after their investments. Top Investors include East Ventures (1 company), elev8 (1 company) and SEEDS Capital (1 company).

Recent News related to Citrine Capital

•
Healthtech Startup Mesh Bio In Singapore Raises $1.8 M In Seed FundingBioSpectrum Asia•Mar 23, 2021•Mesh Bio, Elev8, Seeds Capital, Citrine Capital and 1 other
View all news related to Citrine Capital

FAQs about Citrine Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford